Le Lézard
Classified in: Health
Subjects: LGB, AVO

The Fenway Institute Policy Brief Outlines the Likely Harm to LGBT People from a New Health Care Regulation Proposed by Trump Administration


BOSTON, July 25, 2019 /PRNewswire-PRWeb/ -- Today, The Fenway Institute of Fenway Health released a policy brief outlining the harm to LGBT people likely to result from a new health care regulation proposed by the Trump Administration last month. The public has until August 13, 2019 to offer comment on the proposed regulation, and the authors of the brief urge health care professionals and advocates to submit comment urging the Trump Administration to reconsider the proposal.

The policy brief, "New rule proposes removal of LGBT nondiscrimination provisions from Section 1557 and other health care regulations," is available for download as a PDF here.

On June 14, 2019, the Trump Administration released a proposed regulation that would reverse the 2016 final rule implementing the nondiscrimination provision of the Affordable Care Act (ACA). That measure, known as the 2016 Section 1557 rule explicitly prohibits gender identity discrimination, including discrimination against intersex and non-binary people, in health care facilities and programs receiving federal funding. The rule also prohibits some forms of sexual orientation discrimination that take the form of sex stereotyping.

"Initial news reports about the proposed rule characterized it as anti-transgender," said The Fenway Institute Health Policy Fellow Katherine Laurila, author of the brief, titled "New rule proposes removal of LGBT nondiscrimination provisions from Section 1557 and other health care regulations." "But the scope of the proposed regulation extends far beyond the gender identity and sex stereotyping provisions of the 2016 nondiscrimination provisions of Rule 1557."

Included in the Trump Administration proposal are provisions that would revise several other important health care regulations that explicitly prohibit both sexual orientation and gender identity. If finalized, the proposed rule would remove explicit sexual orientation and gender identity nondiscrimination provisions from:

"This proposed regulation would have far-reaching implications for the LGBT community, all of them negative," said Carl Sciortino, Vice President of Government & Community Relations at Fenway Health. "If this rule is enacted, the Trump Administration will succeed in reversing much of the progress made in federal health policy over the past decade."

Anti-LGBT discrimination in health care is widespread, correlates with poorer health and well-being for LGBT people, and makes LGBT people less likely to access health care. This exacerbates health disparities that LGBT people experience. Since 2011, the Joint Commission has required sexual orientation and gender identity nondiscrimination policies in health care institutions that it accredits. The Joint Commission is a nonprofit organization that accredits hospitals and other health care organizations.

Other anti-LGBT policies enacted by the Trump administration that are harming the health and access to care of LGBT people include:

Other resources on the Trump Administration's actions undermining the right of LGBT people to access health care and other services can also be downloaded as PDFs here:

Since 1971, Fenway Health has been working to make life healthier for the people in our neighborhoods, the LGBT community, people living with HIV/AIDS and the broader population. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues

 

SOURCE Fenway Health


These press releases may also interest you

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

at 12:01
Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be five with no deputy board...



News published on and distributed by: